Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enfusion, Inc.

10.59
-0.4100-3.73%
Post-market: 10.590.00000.00%16:22 EDT
Volume:2.18M
Turnover:23.25M
Market Cap:1.00B
PE:350.44
High:10.92
Open:10.92
Low:10.52
Close:11.00
Loading ...

Clearwater Analytics to Launch $800 Million Senior Secured Term Loan B Facility

MT Newswires Live
·
03 Feb

BRIEF-Clearwater Analytics Announces Launch Of $800 Million Term Loan B

Reuters
·
03 Feb

Clearwater Analytics Holdings: Intends to Use Proceeds From Term Loan to Fund Acquisition of Enfusion

THOMSON REUTERS
·
03 Feb

Clearwater Analytics Announces Launch of $800 Million Term Loan B

Business Wire
·
03 Feb

Clearwater Analytics’ Transformative Acquisition of Enfusion Fuels Growth Potential and Market Expansion

TIPRANKS
·
24 Jan

William Blair downgrades Enfusion (ENFN) to a Hold

TIPRANKS
·
18 Jan

Clearwater Purchase of Enfusion Major Step in Creating Wholesome Software Provider, Morgan Stanley Says

MT Newswires Live
·
18 Jan

BUZZ-Clearwater Analytics rises after Morgan Stanley upgrades to 'overweight'

Reuters
·
17 Jan

MS cuts rating on Enfusion stock after Clearwater’s acquisition bid

Investing.com
·
15 Jan

Exploring Three High Growth Tech Stocks in the United States

Simply Wall St.
·
15 Jan

3 US Stocks Estimated To Be Trading Below Their Intrinsic Value In January 2025

Simply Wall St.
·
14 Jan

Morgan Stanley Downgrades Enfusion to Equalweight From Overweight, Lifts Price Target to $11.25 From $11

MT Newswires Live
·
14 Jan

Enfusion, Inc. : Morgan Stanley Cuts to Equal-Weight From Overweight

THOMSON REUTERS
·
14 Jan

Analysts Have Conflicting Sentiments on These Technology Companies: Clearwater Analytics Holdings (CWAN) and Enfusion (ENFN)

TIPRANKS
·
14 Jan

Enfusion downgraded to Equal Weight from Overweight at Morgan Stanley

TIPRANKS
·
14 Jan

Deals of the day-Mergers and acquisitions

Reuters
·
14 Jan

BofA moves to No Rating on Enfusion after Clearwater Analytics deal

TIPRANKS
·
14 Jan

Sector Update: Tech Stocks Decline Late Afternoon

MT Newswires Live
·
14 Jan

Clearwater-Enfusion merger makes sense strategically, says Oppenheimer

TIPRANKS
·
14 Jan

Enfusion Cut to Market Perform From Outperform by William Blair

Dow Jones
·
14 Jan